Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11161897rdf:typepubmed:Citationlld:pubmed
pubmed-article:11161897lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:11161897lifeskim:mentionsumls-concept:C0028661lld:lifeskim
pubmed-article:11161897lifeskim:mentionsumls-concept:C0079488lld:lifeskim
pubmed-article:11161897lifeskim:mentionsumls-concept:C0699819lld:lifeskim
pubmed-article:11161897lifeskim:mentionsumls-concept:C0010340lld:lifeskim
pubmed-article:11161897lifeskim:mentionsumls-concept:C0392756lld:lifeskim
pubmed-article:11161897lifeskim:mentionsumls-concept:C0011121lld:lifeskim
pubmed-article:11161897lifeskim:mentionsumls-concept:C0085559lld:lifeskim
pubmed-article:11161897lifeskim:mentionsumls-concept:C1706701lld:lifeskim
pubmed-article:11161897pubmed:issue1lld:pubmed
pubmed-article:11161897pubmed:dateCreated2001-2-22lld:pubmed
pubmed-article:11161897pubmed:abstractTextThe prevalence of Helicobacter pylori is increased in healthcare workers and in intensive care nurses. Exposure to H. pylori from gastric secretions and faeces are probably the main sources of transmission to healthcare workers. Routine use of selective decontamination of digestive tract (SDD) in an intensive care unit suppresses H. pylori in critically ill patients. It was questioned whether this suppression and the subsequent decreased exposure to H. pylori for intensive care nurses would lead to a lower prevalence of H. pylori infection. Helicobacter pylori infection prevalence in intensive care nurses from a unit routinely using SDD (group I) was compared to that of nurses from a unit not using SDD (group II). Heathcare workers from other departments of the hospital where no SDD was used (group III) served as a control group. Persons using proton pump inhibitors were excluded. Helicobacter pylori was detected by Laser Assisted Ratio Analyser(13)C-urea breath test (UBT) and serology. This could not be performed in three out of 64 in group I, five out of 55 in group II and five out of 55 in group III (total UBTs = 169). The prevalence of H. pylori infection was 11% (7/61) in group I and 25.5% (14/50) in group II (P= 0.027). In group III, the prevalence of H. pylori infection was 16% (8/45), which was not significantly different from both group I and II. Sero-prevalence in group I was 18.6%, 27% in group II (ns) and 24% in group III. Mean age in the three groups was 35.9, 37.8 and 36.6 years, respectively (ns). In conclusion, the prevalence of H. pylori infection among intensive care nurses is lower in nurses from a unit using SDD compared to a non SDD-using unit. Acquisition of H. pylori by transmission from critically ill patients appears to be diminished through SDD use.lld:pubmed
pubmed-article:11161897pubmed:languageenglld:pubmed
pubmed-article:11161897pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11161897pubmed:citationSubsetIMlld:pubmed
pubmed-article:11161897pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11161897pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11161897pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11161897pubmed:statusMEDLINElld:pubmed
pubmed-article:11161897pubmed:monthJanlld:pubmed
pubmed-article:11161897pubmed:issn0195-6701lld:pubmed
pubmed-article:11161897pubmed:authorpubmed-author:TytgatG NGNlld:pubmed
pubmed-article:11161897pubmed:authorpubmed-author:van der...lld:pubmed
pubmed-article:11161897pubmed:authorpubmed-author:KeseciogluJJlld:pubmed
pubmed-article:11161897pubmed:authorpubmed-author:GeraedtsA AAAlld:pubmed
pubmed-article:11161897pubmed:authorpubmed-author:ZandstraD FDFlld:pubmed
pubmed-article:11161897pubmed:authorpubmed-author:van der...lld:pubmed
pubmed-article:11161897pubmed:authorpubmed-author:van der...lld:pubmed
pubmed-article:11161897pubmed:copyrightInfoCopyright 2001 The Hospital Infection Society.lld:pubmed
pubmed-article:11161897pubmed:issnTypePrintlld:pubmed
pubmed-article:11161897pubmed:volume47lld:pubmed
pubmed-article:11161897pubmed:ownerNLMlld:pubmed
pubmed-article:11161897pubmed:authorsCompleteYlld:pubmed
pubmed-article:11161897pubmed:pagination41-5lld:pubmed
pubmed-article:11161897pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:11161897pubmed:meshHeadingpubmed-meshheading:11161897...lld:pubmed
pubmed-article:11161897pubmed:meshHeadingpubmed-meshheading:11161897...lld:pubmed
pubmed-article:11161897pubmed:meshHeadingpubmed-meshheading:11161897...lld:pubmed
pubmed-article:11161897pubmed:meshHeadingpubmed-meshheading:11161897...lld:pubmed
pubmed-article:11161897pubmed:meshHeadingpubmed-meshheading:11161897...lld:pubmed
pubmed-article:11161897pubmed:meshHeadingpubmed-meshheading:11161897...lld:pubmed
pubmed-article:11161897pubmed:meshHeadingpubmed-meshheading:11161897...lld:pubmed
pubmed-article:11161897pubmed:meshHeadingpubmed-meshheading:11161897...lld:pubmed
pubmed-article:11161897pubmed:meshHeadingpubmed-meshheading:11161897...lld:pubmed
pubmed-article:11161897pubmed:meshHeadingpubmed-meshheading:11161897...lld:pubmed
pubmed-article:11161897pubmed:meshHeadingpubmed-meshheading:11161897...lld:pubmed
pubmed-article:11161897pubmed:meshHeadingpubmed-meshheading:11161897...lld:pubmed
pubmed-article:11161897pubmed:meshHeadingpubmed-meshheading:11161897...lld:pubmed
pubmed-article:11161897pubmed:meshHeadingpubmed-meshheading:11161897...lld:pubmed
pubmed-article:11161897pubmed:meshHeadingpubmed-meshheading:11161897...lld:pubmed
pubmed-article:11161897pubmed:meshHeadingpubmed-meshheading:11161897...lld:pubmed
pubmed-article:11161897pubmed:meshHeadingpubmed-meshheading:11161897...lld:pubmed
pubmed-article:11161897pubmed:meshHeadingpubmed-meshheading:11161897...lld:pubmed
pubmed-article:11161897pubmed:year2001lld:pubmed
pubmed-article:11161897pubmed:articleTitleGut decontamination of critically ill patients reduces Helicobacter pylori acquisition by intensive care nurses.lld:pubmed
pubmed-article:11161897pubmed:affiliationDepartment of Intensive Care, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands. phjvdvoort@wxs.nllld:pubmed
pubmed-article:11161897pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11161897pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:11161897pubmed:publicationTypeControlled Clinical Triallld:pubmed